BFM
ZBH icon

Boothbay Fund Management’s Zimmer Biomet ZBH Stock Holding History

Boothbay Fund Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$1.08M – 1962
2024
Q3 		$1.08M Buy
+10,000
New +$1.09M 0.02% 724

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's ZBH Position: Q1 2026 in Review

Boothbay Fund Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 11,953 shares — an estimated $1.07M sold.

Boothbay Fund Management first reported a position in ZBH in Q2 2015 and held it in 20 quarters. The position peaked at $35.4M in Q3 2023. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Boothbay Fund Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 11,953 Zimmer Biomet shares in Q1 2026, an estimated $1.07M.
  • Boothbay Fund Management first reported a position in Zimmer Biomet in Q2 2015 and held it in 20 quarters.
  • Boothbay Fund Management's Zimmer Biomet position peaked at $35.4M in Q3 2023.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.